XBIOTECH INC. Financing Cash Flow
XBIOTECH INC. (XBIT) reported Financing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- XBIOTECH INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $0.00.
- XBIOTECH INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $0.00.
- XBIOTECH INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- XBIOTECH INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- XBIOTECH INC. net cash provided by (used in) financing activities for fiscal 2025 was -$10.25M, a 198.09% decline from fiscal 2024.
- XBIOTECH INC. net cash provided by (used in) financing activities for fiscal 2024 was $10.45M.
- XBIOTECH INC. net cash provided by (used in) financing activities for fiscal 2023 was -$9.00K.
- XBIOTECH INC. net cash provided by (used in) financing activities for fiscal 2022 was $0.00.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | -$10.25M 10-K · filed 2026-03-13 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | -$10.25M 10-Q · filed 2025-11-12 | -$9.97M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$10.25M 10-Q · filed 2026-08-13 | -$9.97M derived: sum of 3 quarters · filed 2026-08-13 | -$9.90M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$10.25M 10-Q · filed 2026-05-14 | -$9.97M derived: sum of 2 quarters · filed 2026-05-14 | -$9.90M derived: sum of 3 quarters · filed 2026-05-14 | -$9.86M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $347.00K derived: sum of 2 quarters · filed 2026-03-13 | $395.00K derived: sum of 3 quarters · filed 2026-03-13 | $10.45M 10-K · filed 2026-03-13 |
| 2024-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $112.00K derived: sum of 2 quarters · filed 2025-11-12 | $10.17M 10-Q · filed 2025-11-12 | $10.17M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $10.10M 10-Q · filed 2025-08-13 | $10.10M derived: sum of 3 quarters · filed 2025-08-13 | $10.11M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $10.05M 10-Q · filed 2025-05-14 | $10.05M derived: sum of 2 quarters · filed 2025-05-14 | $10.06M derived: sum of 3 quarters · filed 2025-05-14 | $10.05M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $5.00K derived: sum of 2 quarters · filed 2025-03-18 | -$9.00K derived: sum of 3 quarters · filed 2025-03-18 | -$9.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$9.00K derived: sum of 2 quarters · filed 2024-11-13 | -$9.00K 10-Q · filed 2024-11-13 | -$9.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$14.00K 10-Q · filed 2024-08-12 | -$14.00K derived: sum of 3 quarters · filed 2024-08-12 | -$14.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-05-10 | $0.00 derived: sum of 3 quarters · filed 2024-05-10 | $0.00 derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $0.00 derived: sum of 2 quarters · filed 2024-03-15 | $0.00 derived: sum of 3 quarters · filed 2024-03-15 | $0.00 10-K · filed 2024-03-15 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $33.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $33.00K derived: sum of 3 quarters · filed 2023-08-11 | -$72.01M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $33.00K derived: sum of 2 quarters · filed 2023-03-15 | -$72.01M derived: sum of 3 quarters · filed 2023-03-15 | -$68.03M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$72.01M derived: sum of 2 quarters · filed 2023-03-15 | -$68.03M derived: sum of 3 quarters · filed 2023-03-15 | -$67.01M 10-K · filed 2023-03-15 |
| 2021-09-30 | -$72.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$68.06M derived: sum of 2 quarters · filed 2022-11-09 | -$67.04M 10-Q · filed 2022-11-09 | -$67.19M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $5.00M 10-Q · filed 2022-08-10 | $4.85M derived: sum of 3 quarters · filed 2022-08-10 | $7.08M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $1.02M 10-Q · filed 2022-05-10 | $872.00K derived: sum of 2 quarters · filed 2022-05-10 | $3.10M derived: sum of 3 quarters · filed 2022-05-10 | $3.38M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.08M derived: sum of 2 quarters · filed 2022-03-15 | $2.36M derived: sum of 3 quarters · filed 2022-03-15 | -$409.72M 10-K · filed 2022-03-15 |
| 2020-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.51M derived: sum of 2 quarters · filed 2021-11-09 | -$409.57M 10-Q · filed 2021-11-09 | -$406.40M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$411.80M 10-Q · filed 2021-08-09 | -$408.63M derived: sum of 3 quarters · filed 2022-03-15 | -$408.34M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$412.08M 10-Q · filed 2021-05-10 | -$408.91M derived: sum of 2 quarters · filed 2022-03-15 | -$408.62M derived: sum of 3 quarters · filed 2022-03-15 | -$370.73M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $3.46M derived: sum of 2 quarters · filed 2022-03-15 | $41.35M derived: sum of 3 quarters · filed 2022-03-15 | $42.10M 10-K · filed 2022-03-15 |
| 2019-09-30 | $288.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $38.18M derived: sum of 2 quarters · filed 2020-11-09 | $38.92M 10-Q · filed 2020-11-09 | $38.92M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $37.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $38.64M 10-Q · filed 2020-08-10 | $38.64M derived: sum of 3 quarters · filed 2021-03-16 | $38.64M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $741.00K 10-Q · filed 2020-05-11 | $741.00K derived: sum of 2 quarters · filed 2021-03-16 | $741.00K derived: sum of 3 quarters · filed 2021-03-16 | $741.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $201.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $201.00K 10-Q · filed 2019-11-12 | $205.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $201.00K 10-Q · filed 2019-08-09 | $205.00K derived: sum of 3 quarters · filed 2020-03-16 | $250.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $201.00K 10-Q · filed 2019-05-09 | $205.00K derived: sum of 2 quarters · filed 2020-03-16 | $250.00K derived: sum of 3 quarters · filed 2020-03-16 | $811.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $49.00K derived: sum of 2 quarters · filed 2020-03-16 | $610.00K derived: sum of 3 quarters · filed 2020-03-16 | $33.32M 10-K · filed 2020-03-16 |
| 2017-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $606.00K derived: sum of 2 quarters · filed 2018-10-31 | $33.32M 10-Q · filed 2018-10-31 | $35.40M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $561.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $33.27M 10-Q · filed 2018-08-09 | $35.35M derived: sum of 3 quarters · filed 2019-03-15 | $35.51M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $32.71M 10-Q · filed 2018-05-08 | $34.79M derived: sum of 2 quarters · filed 2019-03-15 | $34.95M derived: sum of 3 quarters · filed 2019-03-15 | |
| 2016-12-31 | $2.08M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | $2.24M derived: sum of 2 quarters · filed 2019-03-15 | $2.94M 10-K/A · filed 2019-03-15 | |
| 2016-09-30 | $159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $866.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $707.00K 10-Q · filed 2016-08-12 | |||
| 2015-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $32.00K derived: sum of 2 quarters · filed 2018-03-16 | $75.36M derived: sum of 3 quarters · filed 2018-03-16 | $77.47M 10-K · filed 2018-03-16 |
| 2015-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $75.36M derived: sum of 2 quarters · filed 2016-11-14 | $77.47M 10-Q · filed 2016-11-14 | $123.32M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $75.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $77.44M 10-Q · filed 2016-08-12 | $123.29M derived: sum of 3 quarters · filed 2017-03-16 | $129.03M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $2.11M 10-Q · filed 2016-05-13 | $47.96M derived: sum of 2 quarters · filed 2017-03-16 | $53.70M derived: sum of 3 quarters · filed 2017-03-16 | $53.70M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $45.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $51.59M derived: sum of 2 quarters · filed 2017-03-16 | $51.59M derived: sum of 3 quarters · filed 2017-03-16 | $63.20M 10-K · filed 2017-03-16 |
| 2014-09-30 | $5.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $5.75M derived: sum of 2 quarters · filed 2015-11-13 | $17.35M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $11.61M 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | $11.61M 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | $12.04M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |